Cargando…
Did the NICE guideline for progesterone treatment of threatened miscarriage get it right?
In November 2021, NICE updated its clinical guideline that covers the management of threatened miscarriage in the first trimester. They recommended offering vaginal micronised progesterone twice daily until 16 completed weeks of pregnancy in those with a previous miscarriage. However, the duration o...
Autor principal: | Duncan, W Colin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066946/ https://www.ncbi.nlm.nih.gov/pubmed/35514538 http://dx.doi.org/10.1530/RAF-21-0122 |
Ejemplares similares
-
Threatened miscarriage and recurrent miscarriage: Expert opinions on progesterone therapy and treatment challenges
por: Demir, Süleyman Cansun, et al.
Publicado: (2023) -
Oral versus Vaginal Micronized Progesterone for the Treatment of Threatened Miscarriage
por: Parveen, Rashida, et al.
Publicado: (2021) -
Expectant Management of Miscarriage in View of NICE Guideline 154
por: Rafi, Junaid, et al.
Publicado: (2014) -
Validation of serum progesterone <35nmol/L as a predictor of miscarriage among women with threatened miscarriage
por: Lek, Sze Min, et al.
Publicado: (2017) -
Threatened Miscarriage
por: Lane, W. S.
Publicado: (1893)